Related Experiment Videos
Pancreatic and islet transplantation
1Departments of Surgery and Medicine, McGill University, and The Centre for Pancreatic Diseases, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, L9-424, Montreal, Quebec H3G 1A4, Canada. cxlw@musica.mcgill.ca
Current Gastroenterology Reports
|September 12, 2000
Summary
Current type 1 diabetes therapies focus on transplantation to restore insulin secretion. While pancreas transplantation improves quality of life, islet transplantation offers a promising alternative with potentially lower morbidity and immunosuppression needs.
Area of Science:
- Endocrinology and Metabolism
- Transplantation Immunology
Background:
- Diabetes mellitus is a major global chronic disease.
- Type 1 diabetes management traditionally relies on insulin therapy.
- Restoring insulin secretion via transplantation is a key therapeutic goal.
Purpose of the Study:
- To review current transplantation therapies for type 1 diabetes.
- To compare pancreas transplantation with islet transplantation.
- To highlight the challenges and advancements in diabetes mellitus treatment.
Main Methods:
- Review of current literature on pancreas and islet transplantation.
- Analysis of data from the International Pancreas Transplant Registry.
- Discussion of outcomes, morbidity, and immunosuppression requirements.
Main Results:
- Vascularized pancreas transplantation has increased significantly, with over 10,000 cases reported.
- Pancreas transplantation improves quality of life compared to insulin therapy.
- Shortcomings include high postoperative morbidity and long-term immunosuppression needs.
Conclusions:
- Islet transplantation is an active area of research for type 1 diabetes.
- Islet transplantation aims to restore normoglycemia with reduced morbidity.
- The goal is to achieve efficient diabetes control with less immunosuppression.